Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pharmagen ApS
APS
Active
CVR 36687193
Grusbakken 2D, 2820
Gentofte
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2015 · 11 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Pharmagen ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
DKK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
-16
-14
-10
8
337
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-16
-14
-10
8
337
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-16
-14
-10
8
337
Net financials
52
-5
25
-6
119
Profit before tax
36
-19
15
1
457
Tax
-0
-0
-0
244
73
Net profit
36
-19
15
-242
383
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
973
933
952
966
1.227
Equity
-275
-311
-292
-307
-65
Long-term debt
0
0
0
0
0
Short-term debt
1.248
1.244
1.244
1.273
1.292
Total debt
1.248
1.244
1.244
1.273
1.292
Financial ratios
5-year trend
EBITDA margin (of gross profit)
<−999 %
This company
2021
2025
Equity ratio
-28,3 %
This company
38,2 %
Market median
This company
Market median
174% below market
2021
2025
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2021
2025
Net profit margin (of gross profit)
>999 %
This company
2021
2025
Asset turnover (of gross profit)
-0,02×
This company
2021
2025
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
View
PDF
More on Pharmagen ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
